🇺🇸 FDA
Patent

US 6992108

Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

expired A61KA61K31/07A61K31/19

Quick answer

US patent 6992108 (Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor) held by Ligand Pharmaceuticals Incorporated expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/07, A61K31/19, A61K31/20, A61K31/203